{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:25:58Z","timestamp":1783113958718,"version":"3.54.6"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-12M-1-070"],"award-info":[{"award-number":["2021-12M-1-070"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104013"],"award-info":[{"award-number":["82104013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.118965","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:06:41Z","timestamp":1778861201000},"page":"118965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of the target ANTXR1 and covalent acylation mechanism of 8-esterified cycloberberines against cancer"],"prefix":"10.1016","volume":"315","author":[{"given":"Jia","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xican","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runze","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118965_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejmech.2017.06.019","article-title":"Covalent inhibitors design and discovery","volume":"138","author":"De Cesco","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118965_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/mog2.56","article-title":"Development of covalent inhibitors: principle, design, and application in cancer","volume":"2","author":"Zheng","year":"2023","journal-title":"MedComm-Oncology"},{"key":"10.1016\/j.ejmech.2026.118965_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/ja5112964","article-title":"Mechanistic insights into a classic wonder drug--aspirin","volume":"14","author":"Lei","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118965_bib4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41589-022-01059-7","article-title":"Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation","volume":"18","author":"Fraser","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118965_bib5","first-page":"983","article-title":"Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat","volume":"13","author":"Hempel","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.118965_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108640","article-title":"Evolution of 8-esterified cycloberberines as a novel class of antibacterial agents against MDR gram-positive strains by targeting DNA polymerase IIIC","volume":"163","author":"Fan","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118965_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejmech.2019.02.058","article-title":"Synthesis and biological evaluation of 7-substituted cycloberberine derivatives as potent antibacterial agents against MRSA","volume":"15","author":"Yang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118965_bib8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ejmech.2018.08.050","article-title":"Synthesis and antibacterial evaluation of 13-substituted cycloberberine derivatives as a novel class of anti-MRSA agents","volume":"5","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118965_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejmech.2013.07.026","article-title":"Discovery, synthesis and biological evaluation of cycloprotoberberine derivatives as potential anti-tumor agents","volume":"68","author":"Li","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118965_bib10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.280.5367.1268","article-title":"Aspirin-like molecules that covalently inactivate cyclooxygenase-2","volume":"22","author":"Kalgutkar","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118965_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/jm801157z","article-title":"Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy","volume":"22","author":"Li","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118965_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.118965_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-018-0759-6","article-title":"Cyclizing-berberine A35 induces G2\/M arrest and apoptosis by activating YAP phosphorylation (Ser127)","volume":"4","author":"Zhao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118965_bib14","article-title":"Synthesis and evolution of 16-membered macrolide carrimycin derivatives as a novel class of anti-HCoV-OC43 agents targeting viral FSE RNA","volume":"5","author":"Zhong","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118965_bib15","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1080\/15384101.2023.2275900","article-title":"Depleting ANTXR1 suppresses glioma growth via deactivating PI3K\/AKT pathway","volume":"22","author":"Zhou","year":"2023","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2026.118965_bib16","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1158\/1541-7786.MCR-19-0144","article-title":"Identification of TP53RK-binding protein (TPRKB) dependency in TP53-deficient cancers","volume":"17","author":"Goswami","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118965_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.20892\/j.issn.2095-3941.2020.0136","article-title":"LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients","volume":"9","author":"Tian","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.ejmech.2026.118965_bib18","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.2147\/CMAR.S278902","article-title":"LCN2 mediated by IL-17 affects the proliferation, migration, invasion and cell cycle of gastric cancer cells by targeting SLPI","volume":"14","author":"Xu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ejmech.2026.118965_bib19","article-title":"Acetylcorynoline induces apoptosis and G2\/M phase arrest through the c-Myc signaling pathway in Colon cancer cells","volume":"18","author":"Park","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118965_bib20","first-page":"541","article-title":"Identification of Bruceine A as a novel HSP90AB1 inhibitor for suppressing hepatocellular carcinoma growth","volume":"25","author":"Peng","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejmech.2026.118965_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1520223","article-title":"Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer","volume":"11","author":"Franco","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2026.118965_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108086","article-title":"Lycorine esters exert anti-HCoV-OC43 effect through reversibly acylating cysteine residue in the nsp 12 NiRAN domain","volume":"154","author":"Mei","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118965_bib24","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/ci500118s","article-title":"Docking covalent inhibitors: a parameter free approach to pose prediction and scoring","volume":"54","author":"Zhu","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118965_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155941","article-title":"A phenolic compound from Nostoc commune, ameliorates DSS-induced colitis against oxidative stress via the Nrf2\/HO-1\/NQO-1\/NF-\u03baB\/AP-1 pathway","volume":"133","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2026.118965_bib26","series-title":"Gaussian 09, Revision D.01","author":"Frisch","year":"2010"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:14:18Z","timestamp":1783113258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":25,"alternative-id":["S0223523426004101"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118965","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of the target ANTXR1 and covalent acylation mechanism of 8-esterified cycloberberines against cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118965"}}